Seilern Investment Management Ltd Reduces Stock Position in Intuitive Surgical, Inc. $ISRG

Seilern Investment Management Ltd trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 124,511 shares of the medical equipment provider’s stock after selling 2,306 shares during the period. Intuitive Surgical makes up about 4.5% of Seilern Investment Management Ltd’s holdings, making the stock its 13th largest holding. Seilern Investment Management Ltd’s holdings in Intuitive Surgical were worth $67,661,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the business. Arvest Investments Inc. purchased a new position in Intuitive Surgical in the second quarter worth approximately $297,000. TrueWealth Advisors LLC grew its position in Intuitive Surgical by 5.5% in the second quarter. TrueWealth Advisors LLC now owns 1,138 shares of the medical equipment provider’s stock worth $618,000 after acquiring an additional 59 shares during the period. Norway Savings Bank grew its position in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after acquiring an additional 910 shares during the period. HBW Advisory Services LLC grew its position in Intuitive Surgical by 18.5% in the second quarter. HBW Advisory Services LLC now owns 642 shares of the medical equipment provider’s stock worth $349,000 after acquiring an additional 100 shares during the period. Finally, Neville Rodie & Shaw Inc. grew its position in Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after acquiring an additional 1,110 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 1.4%

NASDAQ:ISRG opened at $449.68 on Friday. The firm has a market cap of $161.20 billion, a PE ratio of 62.72, a price-to-earnings-growth ratio of 4.78 and a beta of 1.61. The stock has a fifty day moving average price of $485.67 and a 200 day moving average price of $508.21. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same period last year, the firm earned $1.78 earnings per share. Intuitive Surgical’s quarterly revenue was up 21.4% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on ISRG. Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. BTIG Research raised their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Piper Sandler restated an “overweight” rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.